General Announcement::Glenmark introduces higher strength (400 mg) of FabiFlu

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
06-Aug-2020 17:08:00
Status
New
Announcement Sub Title
Glenmark introduces higher strength (400 mg) of FabiFlu
Announcement Reference
SG200806OTHRHXHT
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
06/08/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
Glenmark introduces higher strength (400 mg) of FabiFlu to reduce pill burden of COVID-19 treatment

Attachments

PR_SGX_06082020.pdf
Total size =1281K